approved

Приложение 4 на ПЛС от 02.04.2020 г.

Unique identificator:  16567f8c-dc9e-43f9-aafb-76a24c493a59

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-04-02 14:27:22
  • Created by: georgi_sivchev
  • Updated at: 2020-04-02 14:27:22
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Sildenafil EU/1/05/318/003 Revatio, Powder for oral suspension, 10 mg/ml - 90 ml (32,27 g), -, Pack: 1 Pfizer Limited, Обединено Кралство Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Poce-sur-Cisse, Франция 400.69 80.14 480.83 4% 10 410.69 82.14 492.83 16% 25 435.69 87.14 522.83 НСР-7899/25.01.2016.; НСР-10744/27.10.2016; НСР-13504/18.08.2017; НСР-15654/14.05.2018 29.05.2018 02.06.2018 Неактивен 3311
Sildenafil EU/1/05/318/003 Revatio, Powder for oral suspension, 10 mg/ml - 90 ml (32,27 g), -, Pack: 1 Pfizer Limited, Обединено Кралство Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Poce-sur-Cisse, Франция 400.69 80.14 480.83 4% 10 410.69 82.14 492.83 16% 25 435.69 87.14 522.83 НСР-7899/25.01.2016.; НСР-10744/27.10.2016; НСР-13504/18.08.2017; НСР-15654/14.05.2018 29.05.2018 02.06.2018 Неактивен 3311
Sildenafil EU/1/05/318/003 Revatio, Powder for oral suspension, 10 mg/ml - 90 ml (32,27 g), -, Pack: 1 Pfizer Limited, Обединено Кралство Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Poce-sur-Cisse, Франция 419.23 83.85 503.08 4% 10 429.23 85.85 515.08 16% 25 454.23 90.85 545.08 НСР-7899/25.01.2016.; НСР-10744/27.10.2016; НСР-13504/18.08.2017 02.09.2017 02.10.2017 Неактивен 3311
Sildenafil EU/1/05/318/003 Revatio, Powder for oral suspension, 10 mg/ml 90 ml (32,27 g), mg, Pack: 1 Pfizer Limited, Обединено Кралство Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Poce-sur-Cisse, Франция 427.78 85.56 513.34 4% 10 437.78 87.56 525.34 16% 25 462.78 92.56 555.34 НСР-7899/25.01.2016.; НСР-10744/27.10.2016 02.12.2016 02.12.2016 Неактивен 3311
Sildenafil EU/1/05/318/003 Revatio, Powder for oral suspension, 10 mg/ml 90 ml (32,27 g), mg, Pack: 1 Pfizer Limited, Обединено Кралство Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Poce-sur-Cisse, Франция 444.05 88.81 532.86 4% 10 454.05 90.81 544.86 16% 25 479.05 95.81 574.86 НСР-7899/25.01.2016. 09.02.2016 09.02.2016 Неактивен 3311
Sildenafil EU/1/05/318/003 Revatio, Powder for oral suspension, 10 mg/ml 90 ml (32,27 g), mg, Pack: 1 Pfizer Limited, Обединено Кралство Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Poce-sur-Cisse, Франция 444.05 88.81 532.86 4% 10 454.05 90.81 544.86 16% 25 479.05 95.81 574.86 НСР-7899/25.01.2016. 09.02.2016 09.02.2016 Неактивен 3311
Sildenafil EU/1/05/318/003 Revatio, Powder for oral suspension, 10 mg/ml 90 ml (32,27 g), mg, Pack: 1 Pfizer Limited, Обединено Кралство Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Poce-sur-Cisse, Франция 449.33 89.87 539.2 4% 10 459.33 91.87 551.2 16% 25 484.33 96.87 581.2 промяна на обстоятелства Решение НСР-5257/10.12.2014 НСР-4901/22.10.2014 06.11.2014 06.11.2014 Неактивен 3311
Sildenafil EU/1/05/318/003 Revatio, Powder for oral suspension, 10 mg/ml 90 ml (32,27 g), mg, Pack: 1 Pfizer Limited, Обединено Кралство Pfizer PGM, Zone Industries, 37530, Pocesur-Cisse, France 460.75 92.15 552.9 4% 10 470.75 94.15 564.9 16% 25 495.75 99.15 594.9 НСР-2433/21.01.2014 05.02.2014 05.02.2014 Неактивен 3311
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Ирландия Glaxo Wellcome S.A., Испания; Novartis Pharmaceuticals UK Limited, Обединено кралство; Novartis Pharma GmbH, Германия 3128.02 625.6 3753.62 4% 10 3138.02 627.6 3765.62 16% 25 3163.02 632.6 3795.62 Промяна на обстоятелствата НСР-16373/02.08.2018; НСР-17819/24.01.2019 НСР-8242/22.02.2016; НСР-10756/27.10.2016; НСР-17578/20.12.2018; НСР-18294/28.03.2019 04.01.2019 02.05.2019 Заличен 3232
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Ирландия Glaxo Wellcome S.A., Испания; Novartis Pharmaceuticals UK Limited, Обединено кралство; Novartis Pharma GmbH, Германия 3128.02 625.6 3753.62 4% 10 3138.02 627.6 3765.62 16% 25 3163.02 632.6 3795.62 Промяна на обстоятелствата НСР-16373/02.08.2018; НСР-17819/24.01.2019 НСР-8242/22.02.2016; НСР-10756/27.10.2016; НСР-17578/20.12.2018 04.01.2019 02.03.2019 Неактивен 3232
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3128.02 625.6 3753.62 4% 10 3138.02 627.6 3765.62 16% 25 3163.02 632.6 3795.62 Промяна на обстоятелствата НСР-16373/02.08.2018 НСР-8242/22.02.2016; НСР-10756/27.10.2016; НСР-17578/20.12.2018 04.01.2019 02.02.2019 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 Novartis Europharm Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1564 312.8 1876.8 4% 10 1574 314.8 1888.8 16% 25 1599 319.8 1918.8 Промяна на обстоятелствата НСР-16372/02.08.2018 НСР-8676/06.04.2016.; НСР-10996/24.11.2016; НСР-17882/07.02.2019 22.02.2019 02.03.2019 Активен 3568
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 Novartis Europharm Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1586.37 317.27 1903.64 4% 10 1596.37 319.27 1915.64 16% 25 1621.37 324.27 1945.64 Промяна на обстоятелствата НСР-16372/02.08.2018 НСР-8676/06.04.2016.; НСР-10996/24.11.2016 10.12.2016 02.09.2018 Неактивен 3568
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3173.49 634.7 3808.19 4% 10 3183.49 636.7 3820.19 16% 25 3208.49 641.7 3850.19 Промяна на обстоятелствата НСР-16373/02.08.2018 НСР-8242/22.02.2016; НСР-10756/27.10.2016 11.11.2016 02.09.2018 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1586.37 317.27 1903.64 4% 10 1596.37 319.27 1915.64 16% 25 1621.37 324.27 1945.64 НСР-8676/06.04.2016.; НСР-10996/24.11.2016 10.12.2016 02.01.2017 Неактивен 3568
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3173.49 634.7 3808.19 4% 10 3183.49 636.7 3820.19 16% 25 3208.49 641.7 3850.19 НСР-8242/22.02.2016; НСР-10756/27.10.2016 11.11.2016 02.12.2016 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1597.44 319.49 1916.93 4% 10 1607.44 321.49 1928.93 16% 25 1632.44 326.49 1958.93 НСР-8676/06.04.2016. 22.04.2016 22.04.2016 Неактивен 3568
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3232.65 646.53 3879.18 4% 10 3242.65 648.53 3891.18 16% 25 3267.65 653.53 3921.18 НСР-8242/22.02.2016 09.03.2016 09.03.2016 Неактивен 3232
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3232.73 646.55 3879.28 4% 10 3242.73 648.55 3891.28 16% 25 3267.73 653.55 3921.28 промяна обстоятелства НСР-6992/24.08.2015 НСР-6410/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1601.71 320.34 1922.05 4% 10 1611.71 322.34 1934.05 16% 25 1636.71 327.34 1964.05 промяна обстоятелства НСР-6993/24.08.2015 НСР-5575/05.02.2015. 19.02.2015 19.02.2015 Неактивен 3568
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3376.96 675.39 4052.35 4% 10 3386.96 677.39 4064.35 16% 25 3411.96 682.39 4094.35 НСР-4739/02.10.2014 16.10.2014 16.10.2014 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1716.1 343.22 2059.32 4% 10 1726.1 345.22 2071.32 16% 25 1751.1 350.22 2101.32 НСР-3591/23.05.2014 06.06.2014 06.06.2014 Неактивен 3568
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1723.26 344.65 2067.91 4% 10 1733.26 346.65 2079.91 16% 25 1758.26 351.65 2109.91 НСР-857/09.08.2013 02.09.2013 02.09.2013 Неактивен 3568
Eltrombopag EU/1/10/612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 3446.56 689.31 4135.87 4% 10 3456.56 691.31 4147.87 16% 25 3481.56 696.31 4177.87 HCР-306/28.06.2013. 17.07.2013 17.07.2013 Неактивен 3232
Eltrombopag EU/1/10/612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 3833.43 766.69 4600.12 4% 10 3843.43 768.69 4612.12 16% 25 3868.43 773.69 4642.12 КЦ-1683/25.06.2010 15.07.2010 15.07.2010 Неактивен 3232
Showing 12826 to 12851 of 17264 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте